Delay to Treatment and Visual Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration

Podobne zapisy

• Variants in the APOE Gene Are Associated with Improved Outcome after Anti-VEGF Treatment for Neovascular AMD
  od: Wickremasinghe, Sanjeewa S., i wsp.
  Wydane: (2011)
• New era for personalized medicine: the diagnosis and management of age-related macular degeneration
  od: Baird, Paul N, i wsp.
  Wydane: (2009)
• Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
  od: Guymer, Robyn H, i wsp.
  Wydane: (2008)
• Lifetime Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
  od: Finger, Robert P., i wsp.
  Wydane: (2020)
• Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
  od: Guymer, Robyn H., i wsp.
  Wydane: (2013)